Track topics on Twitter Track topics that are important to you
UMS United Medical Systems International AG / Key word(s): Dividend/Dividend
UMS United Medical Systems International AG i. L.:
Final Payment of Liquidation Proceeds to Shareholders
Hamburg, October 12, 2018. The liquidator of UMS United Medical Systems International AG i. L. (UMS, ISIN DE 0005493654 / WKN 549365) (the "Company") has made a final payment of liquidation proceeds to the Company's shareholders, with the consent of the Supervisory Board. An amount of EUR 0.61 will be distributed to each bearer share of no-par-value stock of the Company. The distribution will be made on October 22, 2018 by the custodian banks via Clearstream Banking AG.
Any taxes owed on the final payment at the shareholder level will be determined on the basis of the individual shareholder's situation (e.g. whether the shares are held as part of their personal assets or as part of their business assets). The final payment is a repayment of par value.
The Company in Brief
UMS International AG is a stock corporation listed in the Prime Standard of Deutsche Börse AG. On August 14,2014, the Company sold its interest in United Medical Systems (DE), Inc. and thus sold its entire assets. The Company's Extraordinary General Meeting on September 25, 2014 approved the transfer of assets and liabilities. The agreement was finalized on November 11, 2014. Upon completion of the transfer of assets, the company's corporate purpose was changed to the management of its own assets.
At their annual meeting on April 27, 2015, the shareholders resolved to dissolve the company on April 30, 2015.
Christian Möller, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-Mail:
|Company:||UMS United Medical Systems International AG|
|Borsteler Chaussee 53|
|Phone:||+49 (0)40 - 500 177 - 00|
|Fax:||+49 (0)40 - 500 177 - 77|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|End of Announcement||DGAP News Service|
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...